| Financial Year |
March 31 2023 |
| Monetary Funds |
356,760,397.77 |
| Held-for-trading Financial Assets |
59,105.95 |
| Notes Receivable |
22,986,595.57 |
| Accounts Receivable |
271,403,061.00 |
| Advances to Suppliers |
3,742,049.68 |
| Other Receivables |
7,824,515.41 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
4,633,750.02 |
| Dividend Receivable |
-- |
| Inventories |
151,491,620.42 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
11,962,960.61 |
| Total Current Assets |
956,513,135.94 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
62,827,050.51 |
| Investment Properties |
142,837,410.29 |
| Fixed Assetes |
543,760,515.94 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
58,068,833.92 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
33,207,810.07 |
| Other Non-Current Assets |
14,354,693.92 |
| Sub-Total of Non-Current Assets |
868,831,007.53 |
| Total Assets |
1,825,344,143.47 |
| Short-Term Loans |
78,186,505.91 |
| Trading Financial liabilities |
-- |
| Notes Payable |
11,479,595.55 |
| Accounts Payable |
118,517,315.15 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
7,169,958.75 |
| Taxes Payable |
4,957,337.84 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
6,782,744.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,674,179.95 |
| Other Current Liabilities |
422,071.70 |
| Sub-Total of Current Liabilities |
240,571,417.07 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
3,449,972.34 |
| Deferred Income Tax Liabilities |
1,797,911.72 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
10,993,720.27 |
| Total Liabilities |
251,565,137.34 |
| Paid-In Capital(Or Share Stock) |
351,686,984.00 |
| Capital Surplus |
913,627,202.77 |
| Surplus Reserve |
69,834,309.17 |
| LESS:Treasury Stock |
19,999,072.91 |
| Undistributed Profits |
257,731,509.05 |
| Minority Stockholder's Interest |
937,157.55 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,572,841,848.58 |
| Owner's Equity（Stockholder's Equity） |
1,573,779,006.13 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,825,344,143.47 |
